35
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Angiotensin‐converting enzyme gene polymorphism and coronary reactivity in young men

, , , , , , , , & show all
Pages 596-603 | Received 23 Nov 2006, Accepted 11 Jan 2007, Published online: 08 Jul 2009
 

Abstract

The purpose of the study was to examine whether the insertion/deletion (I/D) polymorphism of the angiotensin‐converting enzyme (ACE) gene affects the vasodilatory properties of coronary arteries in healthy men. The ACE genotypes of 128 men (mean age 35±4 years) were determined and related to myocardial blood flow. The blood flow was measured by positron emission tomography at rest and during vasodilation caused by adenosine or dipyridamole infusion. The coronary flows and resistances at rest and during stimulation with adenosine or dipyridamole did not differ between the ACE genotypes. Furthermore, this polymorphism had no effect on coronary flow reserve corrected by a rate‐pressure product. In conclusion, the ACE I/D polymorphism does not seem to affect myocardial reactivity – an early indicator of atherosclerosis – in healthy subjects.

Acknowledgements

The study was supported by grants from the Medical Research Fund of Tampere University Hospital, the Finnish Cultural Foundation, the Pirkanmaa Fund and the Finnish Fund for Cardiovascular Research. We, the authors, declare that we have no competing interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.